Literature DB >> 16236762

RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration.

Hong Lin1, Jinbin Zhai, William W Schlaepfer.   

Abstract

Abnormal protein aggregation is emerging as a common theme in the pathogenesis of neurodegenerative disease. Our previous studies have shown that overexpression of untranslated light neurofilament (NF-L) RNA causes motor neuron degeneration in transgenic mice, leads to accumulation of ubiquitinated aggregates in degenerating cultured motor neurons and triggers aggregation of NF-L protein and co-aggregation of mutant SOD1 protein in neuronal cells. Here, we report that p190RhoGEF, an RNA-binding protein that binds to a destabilizing element in NF-L mRNA, is involved in aggregation of NF-L protein and is implicated in the pathogenesis of motor neuron degeneration. We show that p190RhoGEF co-aggregates with unassembled NF-L protein and that co-aggregation is associated with down-regulation of parent NF-L mRNA in neuronal cells. Co-expression of NF-M increases NF assembly and reduces RNA-triggered aggregation as well as loss of solubility of NF-L protein. siRNA-induced down-regulation of p190RhoGEF not only reduces aggregation and promotes assembly of NF-L and NF-M, but also causes reversal of aggregation and recovery of NF assembly in transfected cells. Examination of transgenic models of motor neuron disease shows that prominent aggregates of p190RhoGEF and NF-L and down-regulation of NF-L expression occur in degenerating motor neurons of mice expressing untranslated NF-L RNA or a G93A mutant SOD1 transgene. Moreover, aggregates of p190RhoGEF and NF-L appear as early pathological changes in presymptomatic G93A mutant SOD1 transgenic mice. Together, the findings indicate that p190RhoGEF is involved in aggregation of NF-L protein and support a working hypothesis that aggregation of p190RhoGEF and NF-L is an upstream event triggering neurotoxicity in motor neuron disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236762     DOI: 10.1093/hmg/ddi392

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  11 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

2.  A screen to identify cellular modulators of soluble levels of an amyotrophic lateral sclerosis (ALS)-causing mutant SOD1.

Authors:  Balajee R Somalinga; Gregory A Miller; Hiba T Malik; W Christian Wigley; Philip J Thomas
Journal:  J Biomol Screen       Date:  2011-08-29

3.  Molecular entrapment by RNA: an emerging tool for disrupting protein-RNA interactions in vivo.

Authors:  Tarjani N Shukla; Jane Song; Zachary T Campbell
Journal:  RNA Biol       Date:  2020-01-28       Impact factor: 4.652

4.  Gastrin-stimulated Gα13 Activation of Rgnef Protein (ArhGEF28) in DLD-1 Colon Carcinoma Cells.

Authors:  Miriam Masià-Balagué; Ismael Izquierdo; Georgina Garrido; Arnau Cordomí; Laura Pérez-Benito; Nichol L G Miller; David D Schlaepfer; Véronique Gigoux; Anna M Aragay
Journal:  J Biol Chem       Date:  2015-04-28       Impact factor: 5.157

5.  miRNA malfunction causes spinal motor neuron disease.

Authors:  Sharon Haramati; Elik Chapnik; Yehezkel Sztainberg; Raya Eilam; Raaya Zwang; Noga Gershoni; Edwina McGlinn; Patrick W Heiser; Anne-Marie Wills; Itzhak Wirguin; Lee L Rubin; Hidemi Misawa; Clifford J Tabin; Robert Brown; Alon Chen; Eran Hornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-29       Impact factor: 11.205

6.  The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset.

Authors:  Isabelle Maystadt; René Rezsöhazy; Martine Barkats; Sandra Duque; Pascal Vannuffel; Sophie Remacle; Barbara Lambert; Mustapha Najimi; Etienne Sokal; Arnold Munnich; Louis Viollet; Christine Verellen-Dumoulin
Journal:  Am J Hum Genet       Date:  2007-05-16       Impact factor: 11.025

7.  Direct regulation of p190RhoGEF by activated Rho and Rac GTPases.

Authors:  Olugbenga Dada; Stephen Gutowski; Chad A Brautigam; Zhe Chen; Paul C Sternweis
Journal:  J Struct Biol       Date:  2017-11-28       Impact factor: 2.867

8.  Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia.

Authors:  Elizabeth Mercado-Ayón; Nathan Warren; Sarah Halawani; Layne N Rodden; Lucie Ngaba; Yi Na Dong; Joshua C Chang; Carlos Fonck; Fulvio Mavilio; David R Lynch; Hong Lin
Journal:  Front Neurosci       Date:  2022-03-24       Impact factor: 4.677

9.  PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility.

Authors:  Yangmi Lim; Ssang-Taek Lim; Alok Tomar; Margaret Gardel; Joie A Bernard-Trifilo; Xiao Lei Chen; Sean A Uryu; Rafaela Canete-Soler; Jinbin Zhai; Hong Lin; William W Schlaepfer; Perihan Nalbant; Gary Bokoch; Dusko Ilic; Clare Waterman-Storer; David D Schlaepfer
Journal:  J Cell Biol       Date:  2008-01-14       Impact factor: 10.539

Review 10.  The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases.

Authors:  Cristian A Droppelmann; Danae Campos-Melo; Kathryn Volkening; Michael J Strong
Journal:  Front Cell Neurosci       Date:  2014-09-10       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.